Trial Profile
VRC 204 A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiple Strain Ebola DNA Plasmid Vaccine, VRC-EBODNA012-00-VP, in Adult Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs VRC-EBODNA012-00-VP (Primary) ; Ebola virus vaccine
- Indications Ebola virus infections
- Focus Adverse reactions
- 16 Jan 2007 Status change
- 08 Nov 2005 New trial record.